Currently out of the existing stock ratings of Jotin Marango, 7 are a BUY (100%).

Jotin Marango

Work Performance Price Targets & Ratings Chart

Analyst Jotin Marango, currently employed carries an average stock price target met ratio of 33.33% that have a potential upside of 87.93% achieved within 589 days. Previously, Jotin Marango worked at ROTH.

Jotin Marango’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VSTM, Verastem at 14-May-2019.

Wall Street Analyst Jotin Marango

Analyst best performing recommendations are on VSTM (VERASTEM).
The best stock recommendation documented was for VSTM (VERASTEM) at 5/14/2019. The price target of $4 was fulfilled within 344 days with a profit of $2.5 (166.67%) receiving and performance score of 4.84.

Average potential price target upside

AIMT Aimmune Therapeutics VSTM Verastem

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$18

4 years 3 months 24 days ago
(01-Sep-2020)

4/4 (100%)

$3.19 (21.54%)

176

Hold

$34.5

$0.01 (0.03%)

$66

4 years 3 months 24 days ago
(31-Aug-2020)

1/8 (12.5%)

$0.28 (0.82%)

39

Hold

$34.5

$0.01 (0.03%)

$14

4 years 3 months 24 days ago
(31-Aug-2020)

7/7 (100%)

$0.28 (0.82%)

105

Hold

$35

$0.51 (1.48%)

$24

4 years 3 months 24 days ago
(31-Aug-2020)

7/17 (41.18%)

$0.78 (2.28%)

376

Buy

$50

$15.51 (44.97%)

$50

4 years 4 months ago
(25-Aug-2020)

0/5 (0%)

$37.24 (291.85%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jotin Marango?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?